Literature DB >> 9798724

The natural history of asthma.

R A Barbee1, S Murphy.   

Abstract

Our understanding of the natural history of asthma is improving through the establishment of a more precise definition of asthma linked with information from large-scale longitudinal studies. Risk factors for the development of childhood asthma including sex, atopic status, genetic and familial factors, respiratory infections, and outdoor and indoor pollution are now more clearly understood. New information on the relation of viral wheezing episodes in infancy to later childhood asthma is evolving. We now know that children who start wheezing early in life and continue to wheeze at age 6 years are more likely to have a maternal history of asthma, elevated serum IgE levels, and normal lung function in the first year of life. However, at age 6 years they have both elevated serum IgE levels and diminished lung function. Approximately 50% of adults who report having had childhood asthma no longer have symptoms. Airway responsiveness in childhood tends to predict airway responsiveness in adulthood and to be greater in asthmatics with persistent symptoms. Studies of the natural history of asthma support the hypothesis that early therapeutic intervention in mild disease may lead to an improved clinical outcome. Adults exposed to specific occupational environments are at additional risk for the development of asthma. As we learn more about the natural history of asthma, we will have a better understanding of the effect of early diagnosis, environmental control, and therapy on the outcome of the disease.

Entities:  

Mesh:

Year:  1998        PMID: 9798724     DOI: 10.1016/s0091-6749(98)70006-5

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  13 in total

1.  Asthma in young adults: from whence it came?

Authors:  Russell J Hopp
Journal:  Clin Rev Allergy Immunol       Date:  2002-02       Impact factor: 8.667

2.  Income-based drug benefit policy: impact on receipt of inhaled corticosteroid prescriptions by Manitoba children with asthma.

Authors:  A L Kozyrskyj; C A Mustard; M S Cheang; F E Simons
Journal:  CMAJ       Date:  2001-10-02       Impact factor: 8.262

Review 3.  Childhood asthma: causes, epidemiological factors and complications.

Authors:  D J Valacer
Journal:  Drugs       Date:  2000       Impact factor: 9.546

4.  Airway function, inflammation and regulatory T cell function in subjects in asthma remission.

Authors:  Louis-Philippe Boulet; Hélène Turcott; Sophie Plante; Jamila Chakir
Journal:  Can Respir J       Date:  2012 Jan-Feb       Impact factor: 2.409

5.  Assessing health status in Manitoba children: acute and chronic conditions.

Authors:  Anita L Kozyrskyj; G Elske Hildes-Ripstein
Journal:  Can J Public Health       Date:  2002 Nov-Dec

6.  Trimellitic anhydride-induced cellular infiltration into Guinea pig lung varies with age but not gender.

Authors:  Christen P Larsen; Jean F Regal
Journal:  Int Arch Allergy Immunol       Date:  2002-01       Impact factor: 2.749

7.  Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission.

Authors:  M W Pijnenburg; W Hofhuis; W C Hop; J C De Jongste
Journal:  Thorax       Date:  2005-03       Impact factor: 9.139

8.  Temporal change in the prevalence of respiratory symptoms and obstructive airways disease 1993-2001.

Authors:  Peter I Frank; Paul D Wicks; Michelle L Hazell; Mary F Linehan; Sybil Hirsch; Philip C Hannaford; Timothy L Frank
Journal:  Br J Gen Pract       Date:  2005-08       Impact factor: 5.386

Review 9.  Maternal prenatal and/or postnatal n-3 long chain polyunsaturated fatty acids (LCPUFA) supplementation for preventing allergies in early childhood.

Authors:  Anoja W Gunaratne; Maria Makrides; Carmel T Collins
Journal:  Cochrane Database Syst Rev       Date:  2015-07-22

10.  Changed terms for drug payment influenced GPs' diagnoses and prescribing practice for inhaled corticosteroids.

Authors:  Lene G Dalbak; Sture Rognstad; Hasse Melbye; Jørund Straand
Journal:  Eur J Gen Pract       Date:  2013-04-05       Impact factor: 1.904

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.